Bluejay Diagnostics (BJDX) Other Working Capital Changes (2020 - 2026)
Bluejay Diagnostics recorded quarterly Other Working Capital Changes of -$6019.0 in Q1 2026, down 104.65% quarter-over-quarter from $129306.0 in Q4 2025, and up 95.73% year-over-year from -$3075.2 in Q1 2025.
Bluejay Diagnostics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$6019.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 95.73% year-over-year to -$6019.0; the TTM figure through Mar 2026 stood at -$199041.0 (up 40.14% YoY), while the FY2025 annual figure was -$333881.0, down 122.11% from the prior year.
- Other Working Capital Changes came in at -$6019.0 for Q1 2026 at Bluejay Diagnostics, down from $129306.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.0 million in Q4 2022 to a low of -$703542.0 in Q4 2023.
- A 5-year average of -$80921.8 and a median of -$148048.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes tumbled 39284.75% in 2022 and soared 244.06% in 2023, its largest moves.
- Bluejay Diagnostics' Other Working Capital Changes stood at $1.0 million in 2022, then sank by 169.89% to -$703542.0 in 2023, then surged by 69.44% to -$215007.0 in 2024, then surged by 160.14% to $129306.0 in 2025, then slumped by 104.65% to -$6019.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$6019.0, $129306.0, and -$171727.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,019.00 |
| Mar 31, 2026 | -6,019.00 |
| Dec 31, 2025 | 129,306.00 |
| Dec 31, 2025 | 129,306.00 |
| Sep 30, 2025 | -171,727.00 |
| Sep 30, 2025 | -171,727.00 |
| Jun 30, 2025 | -150,601.00 |
| Jun 30, 2025 | -150,601.00 |
| Mar 31, 2025 | -140,859.00 |
| Mar 31, 2025 | -140,859.00 |
| Dec 31, 2024 | -215,007.00 |
| Dec 31, 2024 | -215,007.00 |
| Sep 30, 2024 | -148,048.00 |
| Sep 30, 2024 | -148,048.00 |
| Jun 30, 2024 | 171,415.00 |
| Jun 30, 2024 | 171,415.00 |
| Mar 31, 2024 | 41,315.00 |
| Mar 31, 2024 | 41,315.00 |
| Dec 31, 2023 | -703,542.00 |
| Dec 31, 2023 | -703,542.00 |
| Sep 30, 2023 | -30,707.00 |
| Sep 30, 2023 | -30,707.00 |
| Jun 30, 2023 | -638,500.00 |
| Jun 30, 2023 | -638,500.00 |
| Mar 31, 2023 | 446,532.00 |
| Mar 31, 2023 | 446,532.00 |
| Dec 31, 2022 | 1.01 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | -390,251.00 |
| Sep 30, 2022 | -390,251.00 |
| Jun 30, 2022 | -265,605.00 |
| Jun 30, 2022 | -265,605.00 |
| Mar 31, 2022 | -309,958.00 |
| Mar 31, 2022 | -309,958.00 |
| Dec 31, 2021 | 1.25 Mn |
| Dec 31, 2021 | 1.25 Mn |
| Sep 30, 2021 | 302,149.00 |
| Sep 30, 2021 | 302,149.00 |
| Jun 30, 2021 | 4,212.00 |
| Jun 30, 2021 | 4,212.00 |
| Mar 31, 2021 | -787.00 |
| Mar 31, 2021 | -787.00 |
| Dec 31, 2020 | -788.00 |
| Dec 31, 2020 | -788.00 |